Companies partner with specialized providers to deploy GenAI, agentic AI for improved research, patient care, ISG Provider Lens^® report says

Healthcare and life sciences enterprises are using generative AI (GenAI), agentic AI and analytics to transform patient care and drug development, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm.

The 2025 ISG Provider Lens^® global Specialty Analytics Services — Life Sciences and Healthcare report finds that organizations are adopting new digital tools to deliver better care and patient engagement, accelerate research and improve operations management. They are turning to specialist analytics providers for help integrating these advances and overcoming challenges such as fragmented data and legacy system limitations. The result is measurable improvement in efficiency and patient outcomes.

“Analytics tools for life science and healthcare organizations are becoming more adaptive and predictive,” said Jenn Stein, ISG partner and life sciences industry lead. “Healthcare providers, payers and life sciences organizations see the power in these new technologies and are starting to integrate them in their operations.”

Life sciences firms are accelerating drug discovery and development with AI-enabled simulated trials and more efficient integration of real-world data and evidence, the report says. To improve decentralized clinical trials that use data from wearable devices, they are implementing advanced analytics. Companies are also making complex supply chains more well-connected using analytics, blockchain and IoT, significantly reducing time to market for new products.

Providers are using analytics and AI to strengthen operations amid workforce shortages and financial strain, ISG says. Hospitals and healthcare systems are deploying tools to predict the flow of patients through a facility, helping them allocate staff and resources more effectively. Decision support systems enhanced by GenAI summarize patient histories to help doctors make decisions, while providers are also using AI to improve physician productivity.

Healthcare insurers are expanding their use of advanced analytics beyond actuarial modeling and into fraud and anomaly detection, the report says. Case managers now use agentic AI copilots for real-time recommendations when they are interacting with patients. These tools not only control costs but increase trust among insurers, members and regulators.

Service providers specializing in the healthcare and life sciences industries are unifying data, analytics and AI into modular, interoperable platforms, ISG says. These often include domain-specific AI models, GenAI prompts and agentic AI copilots, along with frameworks for monitoring and retraining AI models to avoid bias. The platforms also offer cloud-native scalability and data pipelines that can ingest and clean diverse datasets.

“GenAI and agentic AI are now the foundations of long-term competitiveness in healthcare and life sciences,” said Manav Deep Sachdeva, senior manager and principal analyst, ISG Provider Lens Research, and lead author of the report. “Providers that specialize in these fields are key partners for gaining real benefits from analytics strategies.”

The report also explores other AI and analytics trends in healthcare and life sciences, including the use of AI to produce documentation, summarize health records and identify quick opportunities for efficiency.

For more insights into the analytics challenges facing healthcare and life sciences organizations, plus ISG’s advice for overcoming them, see the ISG Provider Lens^® Focal Points briefing here.

The 2025 ISG Provider Lens^® global Specialty Analytics Services — Life Sciences and Healthcare report evaluates the capabilities of 21 providers across one quadrant: Life Sciences and Healthcare.

The report names Axtria, CitiusTech, Fractal Analytics, HARMAN Digital Transformation Solutions, MathCo, Quantiphi, Straive and ZS as Leaders in the quadrant.

In addition, Tiger Analytics is named as a Rising Star — a company with a “promising portfolio” and “high future potential” by ISG’s definition — in the quadrant.

The 2025 ISG Provider Lens^® global Specialty Analytics Services — Life Sciences and Healthcare report is available to subscribers or for one-time purchase on this webpage.

About ISG Provider Lens^® Research

The ISG Provider Lens^® Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG's global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG's enterprise clients. The research currently covers providers offering their services globally, across Europe, as well as in the U.S., Canada, Mexico, Brazil, the U.K., France, Benelux, Germany, Switzerland, the Nordics, Australia and Singapore/Malaysia, with additional markets to be added in the future. For more information about ISG Provider Lens research, please visit this webpage.

About ISG

ISG (Nasdaq: III) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world’s top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data, in-depth knowledge of provider ecosystems, and the expertise of its 1,600 professionals worldwide working together to help clients maximize the value of their technology investments.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250924220380/en/

Analytics tools for life science and healthcare organizations are becoming more adaptive and predictive. Healthcare providers, payers and life sciences organizations see power in these technologies and are starting to integrate them in their operations.